ESCUCHE
Live / Registered — Registered (as of 05 Oct 2021)
What this means for you
Registered since 05 Oct 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 05 Oct 2027, and its filing window is open now).
Record
- Serial number
- 90062842
- Registration number
- 6512635
- Mark type
- Design + words
- Filed
- 20 Jul 2020
- Published for opposition
- 06 Oct 2020
- Registered
- 05 Oct 2021
- Next maintenance filing
- §8 declaration of use, due by 05 Oct 2027 (grace period to 05 Apr 2028)
- Attorney of record
- Avraham Schwartz
Goods and services
- Class 035 — Advertising and business services: Promoting public interest and awareness of and understanding of cardiovascular and structural heart disease
- Class 044 — Medical, beauty and agricultural services: Providing health information in the field of structural heart disease; Providing medical information in the field of structural heart disease; Providing a website featuring information in the field of structural heart disease and cardiovascular health
Owner
- Edwards Lifesciences Corporation, Irvine, CA, US
- Edwards Lifesciences Corporation, Irvine, CA, US
- Edwards Lifesciences Corporation, Irvine, CA, US
Prosecution history
- 05 Oct 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
- 01 Sept 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Aug 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Aug 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Aug 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Aug 2021 — ASSIGNED TO LIE
- 17 Aug 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Jul 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Jul 2021 — NON-FINAL ACTION E-MAILED
- 28 Jul 2021 — SU - NON-FINAL ACTION - WRITTEN
- 21 Jul 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Jul 2021 — USE AMENDMENT FILED
- 21 Jul 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jul 2021 — TEAS STATEMENT OF USE RECEIVED